Free Trial

Global X Genomics & Biotechnology ETF (GNOM) Short Interest Ratio & Short Volume

$11.37
+0.10 (+0.89%)
(As of 07/15/2024 ET)

Global X Genomics & Biotechnology ETF Short Interest Data

Current Short Interest
10,700 shares
Previous Short Interest
15,900 shares
Change Vs. Previous Month
-32.70%
Dollar Volume Sold Short
$111,708.00
Short Interest Ratio
0.2 Days to Cover
Last Record Date
June 30, 2024
Outstanding Shares
8,960,000 shares
Percentage of Shares Shorted
0.12%
Today's Trading Volume
93,113 shares
Average Trading Volume
63,818 shares
Today's Volume Vs. Average
146%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Global X Genomics & Biotechnology ETF ?

Sign up to receive the latest short interest report for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GNOM Short Interest Over Time

GNOM Days to Cover Over Time

GNOM Percentage of Float Shorted Over Time

Global X Genomics & Biotechnology ETF Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202410,700 shares $111,708.00 -32.7%N/A0.2 $10.44
6/15/202415,900 shares $166,314.00 +62.2%N/A0.3 $10.46
5/31/20249,800 shares $99,470.00 -31.9%N/A0.2 $10.15
5/15/202414,400 shares $157,248.00 -22.6%N/A0.2 $10.92
4/30/202418,600 shares $183,210.00 +69.1%N/A0.2 $9.85
4/15/202411,000 shares $112,750.00 No ChangeN/A0.1 $10.25
3/31/202411,000 shares $125,180.00 -77.9%N/A0.2 $11.38
3/15/202449,800 shares $571,206.00 -12.0%N/A0.7 $11.47
2/29/202456,600 shares $678,068.00 +133.9%N/A0.7 $11.98
2/15/202424,200 shares $276,848.00 +15.8%N/A0.4 $11.44
1/31/202420,900 shares $224,675.00 -20.8%N/A0.3 $10.75
1/15/202426,400 shares $299,376.00 +80.8%N/A0.1 $11.34
12/31/202314,600 shares $168,748.26 -9.9%N/A0.1 $11.56
12/15/202316,200 shares $183,546.00 -61.6%N/A0.1 $11.33
11/30/202342,200 shares $439,724.00 +47.6%N/A0.1 $10.42
11/15/202328,600 shares $287,716.00 -41.3%N/A0.1 $10.06
10/31/202348,700 shares $430,995.00 -28.5%N/A0.2 $8.85
10/15/202368,100 shares $661,932.00 -14.8%N/A0.3 $9.72
9/30/202379,900 shares $812,583.00 +415.5%N/A0.4 $10.17
9/15/202315,500 shares $168,795.00 -95.9%N/A0.1 $10.89
8/31/2023374,700 shares $4.21 million +4,963.5%N/A3.5 $11.23
8/15/20237,400 shares $82,880.00 -54.9%N/A0.1 $11.20
7/31/202316,400 shares $201,228.00 -64.7%N/A0.2 $12.27
7/15/202346,400 shares $568,864.00 -32.0%N/A0.8 $12.26
6/30/202368,200 shares $826,584.00 +44.8%N/A0.9 $12.12
6/15/202347,100 shares $607,590.00 -32.2%N/A0.6 $12.90
5/31/202369,500 shares $849,290.00 +100.9%N/A0.8 $12.22
5/15/202334,600 shares $452,222.00 +16.1%N/A0.4 $13.07
4/30/202329,800 shares $365,348.00 -60.5%N/A0.3 $12.26
4/15/202375,400 shares $944,762.00 -26.7%N/A0.8 $12.53
3/31/2023102,800 shares $1.27 million +139.6%N/A1.1 $12.32
3/15/202342,900 shares $526,383.00 +29.2%N/A0.5 $12.27
2/28/202333,200 shares $419,316.00 -61.4%N/A0.3 $12.63
2/15/202386,100 shares $1.14 million -13.3%N/A0.9 $13.29
1/31/202399,300 shares $1.35 million -23.7%N/A1 $13.58
1/15/2023130,200 shares $1.77 million +45.0%N/A1.3 $13.60
12/30/202289,800 shares $1.14 million -15.1%N/A0.8 $12.65
12/15/2022105,800 shares $1.39 million +63.8%N/A1 $13.09
11/30/202264,600 shares $872,100.00 +36.6%N/A0.7 $13.50
11/15/202247,300 shares $648,956.00 +48.3%N/A0.5 $13.72
This is HOW many elite traders think (Ad)

Want a preview of how elite traders think?! For a limited time, you can claim AI SMS alerts from TradeAlgo for FREE.

So, hurry and click here to claim your FREE SMS alerts now.
10/31/202231,900 shares $419,485.00 -55.8%N/A0.3 $13.15
10/15/202272,100 shares $876,015.00 No ChangeN/A0.7 $12.15
9/30/2022110,000 shares $1.38 million -60.7%N/A1 $12.55
9/15/2022279,900 shares $3.97 million +232.0%N/A2.2 $14.19
8/31/202284,300 shares $1.17 million -43.7%N/A0.6 $13.83
8/15/2022149,800 shares $2.44 million +22.0%N/A1.1 $16.28
7/31/2022122,800 shares $1.75 million -25.3%N/A0.6 $14.24
7/15/2022164,400 shares $2.32 million -23.2%N/A0.8 $14.09
6/30/2022214,100 shares $2.62 million +237.2%N/A1.1 $12.22
6/15/202263,500 shares $706,120.00 +56.0%N/A0.4 $11.12
5/31/202240,700 shares $488,400.00 +2.8%N/A0.3 $12.00
5/15/202239,600 shares $467,676.00 -44.2%N/A0.2 $11.81
4/30/202271,000 shares $904,540.00 +30.3%N/A0.7 $12.74
4/15/202254,500 shares $790,250.00 +16.2%N/A0.5 $14.50
3/31/202246,900 shares $704,907.00 -1.3%N/A0.4 $15.03
3/15/202247,500 shares $644,100.00 -57.7%N/A0.3 $13.56
2/28/2022112,300 shares $1.74 million +18.7%N/A0.8 $15.46
2/15/202294,600 shares $1.54 million -0.9%N/A0.7 $16.31
1/31/202295,500 shares $1.54 million +41.3%N/A0.7 $16.14
1/15/202267,600 shares $1.16 million -18.5%N/A0.5 $17.22
12/31/202182,900 shares $1.65 million +18.8%N/A0.7 $19.85
12/15/202169,800 shares $1.42 million -30.8%N/A0.7 $20.38
11/30/2021100,800 shares $2.08 million +72.9%N/A1.1 $20.62
11/15/202158,300 shares $1.23 million -20.6%N/A0.6 $21.02
10/29/202173,400 shares $1.57 million +1.4%N/A0.9 $21.43
10/15/202172,400 shares $1.55 million +11.9%N/A0.9 $21.46
9/30/202164,700 shares $1.43 million -55.8%N/A0.8 $22.14
9/15/2021146,200 shares $3.43 million +56.5%N/A1.6 $23.46
8/31/202193,400 shares $2.25 million -31.2%N/A1 $24.12
8/13/2021135,700 shares $3.12 million +18.8%N/A1.5 $22.98
7/30/2021114,200 shares $2.62 million +13.0%N/A1.3 $22.93
7/15/2021101,100 shares $2.29 million -14.7%N/A1.1 $22.64
6/30/2021118,500 shares $2.95 million -4.1%N/A1.2 $24.89
6/15/2021123,500 shares $2.82 million +17.6%N/A1.1 $22.83
5/28/2021105,000 shares $2.26 million -48.8%N/A1 $21.50
5/14/2021205,000 shares $4.05 million +42.7%N/A1.6 $19.75
4/30/2021143,700 shares $3.29 million -30.7%N/A0.9 $22.87
4/15/2021207,300 shares $4.67 million +33.1%N/A1.3 $22.55
3/31/2021155,800 shares $3.34 million -4.3%N/A0.9 $21.44
3/15/2021162,800 shares $3.82 million +59.9%N/A0.9 $23.45
2/26/2021101,800 shares $2.42 million -75.1%N/A0.6 $23.77
2/12/2021408,900 shares $11.23 million +228.2%N/A2.8 $27.47
1/29/2021124,600 shares $3.12 million -15.4%N/A1.1 $25.07
1/15/2021147,300 shares $3.88 million No ChangeN/A1.6 $26.32

GNOM Short Interest - Frequently Asked Questions

What is Global X Genomics & Biotechnology ETF's current short interest?

Short interest is the volume of Global X Genomics & Biotechnology ETF shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 10,700 shares of GNOM short. Learn More on Global X Genomics & Biotechnology ETF's current short interest.

Is Global X Genomics & Biotechnology ETF's short interest increasing or decreasing?

Global X Genomics & Biotechnology ETF saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 10,700 shares, a decrease of 32.7% from the previous total of 15,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Global X Genomics & Biotechnology ETF's short interest compare to its competitors?
Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

What does it mean to sell short Global X Genomics & Biotechnology ETF stock?

Short selling GNOM is an investing strategy that aims to generate trading profit from Global X Genomics & Biotechnology ETF as its price is falling. GNOM shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Global X Genomics & Biotechnology ETF?

A short squeeze for Global X Genomics & Biotechnology ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNOM, which in turn drives the price of the stock up even further.

How often is Global X Genomics & Biotechnology ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNOM, twice per month. The most recent reporting period available is June, 30 2024.



This page (NASDAQ:GNOM) was last updated on 7/16/2024 by MarketBeat.com Staff

From Our Partners